Potential New Therapeutic Approach for Pancreatic Cancer is proposed at 2022 Keystone Meeting: Blocking Obesity or Fatty Acid Oxidation
Potential New Therapeutic Approach for Pancreatic Cancer is proposed at 2022 Keystone Meeting: Blocking Obesity or Fatty Acid Oxidation

Seoul, Korea, September 08, 2022 – (SEAPRWire) – In “the immunometabolism at the crossroads of obesity and cancer, Keystone Symposia (Sept. 5-9, 2022, Keystone, Co, USA)”, Dr. Soo-Youl Kim, Principal Scientist of the National Cancer Center of South Korea, showed that cancer obtains energy absolutely by burning fatty acids from blood as well as that obesity causes cancer... » read more

FDA Grants De Novo Marketing Authorization to Apollo Endosurgery for Apollo ESG and Apollo REVISE, New Endoscopic Systems for Patients with Obesity
FDA Grants De Novo Marketing Authorization to Apollo Endosurgery for Apollo ESG and Apollo REVISE, New Endoscopic Systems for Patients with Obesity

AUSTIN, TX, Jul 13, 2022 – (ACN Newswire via SEAPRWire.com) – Apollo Endosurgery, Inc. (“Apollo”) (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announced today the marketing authorization of the Apollo ESG(TM), Apollo ESG Sx(TM), Apollo REVISE(TM) and Apollo REVISE Sx(TM) Systems through the U.S. Food and Drug Administration’s... » read more